VeriMommedicago sativa leaf extract은 임신 중 안전한가요?
No EU Annex II/III listing or harmonised CLP classification was identified for Medicago sativa (alfalfa) leaf/plant extracts; therefore there is no regulatory reproductive hazard (h>0) from EU lists or harmonised H‑codes. Some literature and reviews note alfalfa contains saponins and phytoestrogenic constituents (theoretical mechanism for reproductive effects), but I found no peer‑reviewed in vivo developmental/teratogenic evidence in humans or harmonised H361/H360 classifications. Sources: CosIng listing (ingredient in EU cosmetics inventory), PubMed studies on saponins/phytoestrogens and in vitro cytotoxicity, EMA summary mentioning saponins.
Pregnancy-safe products containing medicago sativa leaf extract
Related ingredients
Frequently asked questions
- medicago sativa leaf extract은 임신 중 안전한가요?
- No EU Annex II/III listing or harmonised CLP classification was identified for Medicago sativa (alfalfa) leaf/plant extracts; therefore there is no regulatory reproductive hazard (h>0) from EU lists or harmonised H‑codes. Some literature and reviews note alfalfa contains saponins and phytoestrogenic constituents (theoretical mechanism for reproductive effects), but I found no peer‑reviewed in vivo developmental/teratogenic evidence in humans or harmonised H361/H360 classifications. Sources: CosIng listing (ingredient in EU cosmetics inventory), PubMed studies on saponins/phytoestrogens and in vitro cytotoxicity, EMA summary mentioning saponins.
- medicago sativa leaf extract은 모유 수유 중 안전한가요?
- Same rationale as pregnancy: no regulatory ban/restriction or harmonised reproductive classification; phytoestrogen content and saponins are theoretical concerns for hormonal activity but no direct evidence of adverse effects in lactation or transfer via breastmilk for topical cosmetic use was found.
- medicago sativa leaf extract은 아기 피부에 안전한가요?
- No direct evidence of developmental toxicity from topical use. Mechanistically, phytoestrogens/saponins are a theoretical mechanism (m=1). Per the user rules, topical cosmetic exposure in adults has low systemic absorption (e=0); because infant skin (0–3 yr) has higher permeability, exposure score is increased by +1 to e=1. No infant‑specific toxicity or harmonised classification was identified.
- VeriMom은 medicago sativa leaf extract을 어떻게 평가하나요?
- VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 medicago sativa leaf extract을 93/100 (알려진 위험 없음)로 평가합니다.
- 임신 중 medicago sativa leaf extract 대체 안전 성분은?
- 유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.
모든 성분표를 2초 만에 확인
VeriMom 무료 다운로드 — 어떤 제품이든 스캔해 임신 중 안전 점수를 즉시 확인하세요.
의료 면책 조항
이 정보는 교육 목적으로만 제공되며 의학적 조언을 구성하지 않습니다. 안전 점수는 공개적으로 이용 가능한 데이터를 기반으로 하며 모든 위험을 반영하지 않을 수 있습니다. 임신 중 또는 수유 중 제품을 사용하기 전에 항상 의료 전문가와 상담하십시오.